CJC-1295 No DAC

Growth Hormone Releasing Hormone Analog

CJC-1295 No DAC is a synthetic analog of growth hormone releasing hormone (GHRH), formulated without the Drug Affinity Complex for a shorter half-life and pulsatile activity profile. It is widely studied in scientific literature for its role in cellular processes related to GHRH receptor signaling and pituitary interaction.

Within research environments, CJC-1295 No DAC is frequently referenced in studies exploring growth hormone secretion patterns and receptor-mediated signaling. Its structure allows for targeted investigation into biological systems associated with pulsatile peptide release, somatotropic axis activity, and downstream signaling cascades.

Ongoing laboratory and academic research continues to examine CJC-1295 No DAC’s broader role in GHRH pathways, receptor interaction, and biochemical activity. Its short-acting profile makes it a consistent focus in advanced peptide pulsatility and combination research.

Research Focus Areas

• GHRH receptor signaling pathways

• Pulsatile peptide release mechanisms

• Somatotropic axis interaction studies

• Combination peptide research models

Notice: This material is intended for educational and research use only by qualified professionals. It is not approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, or prevention of any disease. No clinical use guidance is provided.